We had recently reported that the CD90 was up-regulated in liver cirrhosis and HCC compared to normal tissue [17] and data from Yamashita et al. had shown that the tumorigenicity of the CSC CD90+ cells might appear in the late stages of hepatocarcinogenesis with the preference to HBV-related HCC [18]. The gene discussed is THY1; the disease is cirrhosis of liver.